Apparatus for urea photo-oxidation
15 claims: 1 independent, 14 dependent
- 1A dialysis fluid regeneration system, comprising:a nanostructured anode (722);a source of light (750) configured to illuminate the anode;and a cathode (742) that is oxygen permeable, the cathode being an air permeable cathode that blocks liquids but passes gases through;wherein the system is configured to regenerate a dialysis fluid by flowing the dialysis fluid through the system and illuminating the anode with the source of light as the dialysis fluid passes over the anode, thereby photo-electrochemically eliminating urea in the dialysis fluid.
45 paragraphs in 5 sections, as filed
CROSS-REFERENCE TO RELATED APPLICATION
0001This application claims the benefit of <patcit id="pcit0001" dnum="US62719549" dnum-type="L"><text>U.S. Provisional Application No. 62/719549, filed August 17, 2018</text></patcit>.
BACKGROUND
0002More than 2 million end-stage renal disease (ESRD) patients worldwide receive dialysis to sustain life, with this number likely to represent less than 10% of the actual need. In the United States alone, over 460,000 people are on kidney dialysis, over 89,000 of whom die annually with a 5-year survival rate being only 35%. The intermittent character of hemodialysis causes large fluctuations in blood metabolite concentrations. Observations show that long-term survival in dialysis is improved for the patients treated by extended hemodialysis (i.e., more frequent or with longer hours of treatment) when compared to conventional hemodialysis.
0003<figref idref="f0001">Figure 1</figref> is a plan view of a conventional dialysis system 10. In operation, a patient 5 is connected to the dialysis system 10 such that patient's blood flows through a tubing 14 into a dialysis system 10. The tubing 14 is threaded through a blood pump 18. The pumping action of the blood pump 18 pushes patient's blood through the dialysis system 10 and back into patient's body. The pump 18 is typically a non-contact pump.
0004Dialysate 12 is a fluid that helps remove the unwanted waste products (e.g., urea) from patient's blood. During the dialysis, dialysate 12 and patient's blood flow through the dialysis system 10, but the two flows do not physically mix. Instead, fresh dialysate 12 from the machine is separated by a membrane from the blood flow. Impurities from patient's blood stream are filtered out through the membrane into dialysate 12. For example, typically 12-24 g of urea needs to be removed daily in a normal adult, but with a reduced protein diet 15g day is a sufficient goal. Other impurities are also filtered out of the blood stream into the dialysate. Dialysate containing unwanted waste products and excess electrolytes leave the dialyzer for disposal.
0005Since hemodialysis works on the principle of diffusion into a dialysate having low target concentration, inherently large volumes of fluid are required. The conventional hemodialysis achieves the removal of excessive metabolic waste from the body by running about 120 liters of dialysate per session, which typically requires 3-4 hours of treatment. The dialysis may be required three times a week. Patients are subjected to significant life disruptions, including having to be immobilized for hours and having to arrange transportation to dialysis centers, which impact their quality of life. Accordingly, systems and method for improved dialysis, including improved urea removal, are required.
0006<nplcit id="ncit0001" npl-type="s"><text>Kaneko et al. (Journal of Photochemistry and Photobiology, vol. 205, no. 2-3, p. 168-172</text></nplcit>) describe a biophotochemical cell comprising a nanoporous TiO2 photoanode (film) and an O2-reducing cathode for decomposition of biomass wastes. <patcit id="pcit0002" dnum="KR20180089153A"><text>KR20180089153A</text></patcit> describes a photocatalytic urea decomposition method using a titanium dioxide photocatalyst. <nplcit id="ncit0002" npl-type="s"><text>Park et al. (Environ. Sci. Pollut. Res. (2019) 26: 1044-1053</text></nplcit>) compare photocatalytic oxidation of urea on TiO2 in water and urine.
SUMMARY
0007This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This summary is not intended to identify key features of the claimed subject matter. The invention is defined by the appended claims.
0008Briefly, the inventive technology is directed to urea removal from a dialysate. The inventive technology may be used for dialysis, including kidney dialysis, hemodialysis, hemofiltration, hemodiafiltration, removal of impurities, etc. photo-chemical oxidation (also referred to as "dialysis-fluid regeneration" or "urea treatment") removes urea from dialysate. A dialysis system fluid regeneration system includes : a nanostructured anode; a source of light configured to illuminate the anode; and a cathode that is oxygen permeable, the cathode being an air permeable cathode that blocks liquids but passes gases through. The system is configured to regenerate a dialysis fluid by flowing the dialysis fluid through the system and illuminating the anode with the source of light as the dialysis fluid passes over the anode, thereby photo-electrochemically eliminating urea in the dialysis fluid. The nanostructures may be TiO2 nanowires that are hydrothermally grown. The source of light may be provided by an array of LEDs. The oxygen permeable or air permeable cathode may be a platinum-coated (Pt-coated) cloth or paper.
0009In some embodiments, the system may be sized down enough to become wearable and/or portable. Wearable dialysis devices not only achieve continuous dialysis, but also help reduce clinic related treatment costs and improve quality of life through enhanced mobility.
DESCRIPTION OF THE DRAWINGS
0010The foregoing aspects and many of the attendant advantages of the inventive technology will become more readily appreciated as the same are understood with reference to the following detailed description, when taken in conjunction with the accompanying drawings, wherein: <ul id="ul0001" list-style="none" compact="compact"><li><figref idref="f0001">FIGURE 1</figref> is a plan view of a dialysis system in accordance with conventional technology;</li><li><figref idref="f0002">FIGURE 2</figref> is a schematic diagram of a dialysis system in accordance with an embodiment of the present technology;</li><li><figref idref="f0003">FIGURE 3</figref> is a schematic diagram of a dialysis system in operation in accordance with an embodiment of the present technology;</li><li><figref idref="f0004">FIGURE 4A</figref> is an exploded view of a urea treatment unit in accordance with an embodiment of the present technology;</li><li><figref idref="f0004">FIGURE 4B</figref> is a schematic view of a urea treatment unit in operation in accordance with an embodiment of the present technology;</li><li><figref idref="f0005">FIGURE 5A</figref> is an exploded view of a urea treatment unit in accordance with an embodiment of the present technology;</li><li><figref idref="f0006">FIGURE 5B</figref> is an exploded view of a urea treatment unit in accordance with an embodiment of the present technology;</li><li><figref idref="f0007">FIGURES 6A and 6B</figref> are microscope images of nanostructures in accordance with an embodiment of the present technology;</li><li><figref idref="f0008">FIGURE 7</figref> is a schematic view of a urea treatment unit in accordance with an embodiment of the present technology;</li><li><figref idref="f0009">FIGURE 8</figref> is flow diagram of a urea treatment unit in accordance with an embodiment of the present technology;</li><li><figref idref="f0010">FIGURE 9</figref> is a schematic view of a portable urea dialysis system in accordance with an embodiment of the present technology;</li><li><figref idref="f0011 f0012 f0013 f0014">FIGURES 10A-10D</figref> are schematic views of portable dialysis systems in accordance with embodiments of the present technology;</li><li><figref idref="f0015">FIGURE 11</figref> is a graph of photocurrent in accordance with an embodiment of the present technology;</li><li><figref idref="f0016">FIGURE 12</figref> is a graph of photocurrent as a function of hydrothermal growth time in accordance with an embodiment of the present technology;</li><li><figref idref="f0017">FIGURE 13</figref> is a graph of absorbance as a function of wavelength in accordance with an embodiment of the present technology;</li><li><figref idref="f0018">FIGURE 14</figref> is a graph of photocurrent as a function of effective LED current in accordance with an embodiment of the present technology; and</li><li><figref idref="f0019">FIGURE 15</figref> is a performance comparison between a Pt-coated and a Pt-black cathode in accordance with an embodiment of the present technology; and</li><li><figref idref="f0020">FIGURE 16</figref> is a graph of photocurrent as a function of time in accordance with an embodiment of the present technology.</li></ul>
DETAILED DESCRIPTION
0011While several embodiments have been illustrated and described, it will be appreciated that various changes can be made therein without departing from the scope of the claimed subject matter.
0012<figref idref="f0002">Figure 2</figref> is a schematic diagram of a dialysis system in accordance with an embodiment of the present technology. The illustrated system (e.g., a kidney dialysis system, hemodialysis, hemodiafiltration or a hemofiltration system) includes a urea oxidation unit 700 and a toxin selective removal unit 600. In operation, flow of blood 410 that includes urea and other toxins enters the urea oxidation unit 700. The flow of blood 410 is separated from a flow of dialysate fluid (e.g., dialysate) 715 by a membrane 712, which allows mass exchange for select molecules between the flow of blood and the flow of dialysate fluid (referred to as "dialysate" for simplicity). In some embodiments, a low molecular weight cut-off dialysis membrane allows only small molecules (e.g., less than 100 Da) to pass through. In some embodiments, the membrane may be a reverse osmosis (RO) membrane. In some embodiments, the urea oxidation unit 700 includes a photo-chemical oxidation unit 720 (also referred to as a "dialysis-fluid regeneration unit", or a "urea treatment unit") that is configured to remove urea, and a radical/trace scavenger 780 that is configured to remove oxidative byproducts, radical byproducts, chlorine, and/or other toxins. The photo-chemical oxidation unit 720 is described in more detail with reference to <figref idref="f0004 f0005 f0006 f0007 f0008 f0009">Figures 4A to 8</figref> below. Terms "photo-oxidation," "photochemical oxidation," and "photo-chemical oxidation" are used interchangeably in this specification.
0013In some embodiments, after urea and/or other small molecule toxins are removed from the blood flow 410, thus partially cleaned blood flow 414 continues to flow toward a protein-bound toxin selective removal unit 600. The blood flow 414 is separated from cellular components by a membrane 612 that is configured for passing large molecular weight proteins and small molecules, commonly referred to as blood plasma. On the permeate side of membrane 612 are selective sorbents for clearance of larger molecular weight and/or protein-bound toxins. This solution 614 flows through a membrane 613 into unit 650 with a mixture of sorbents and selective membranes for the removal of small molecule toxins through flow 610. Nutrients are returned to blood stream 416 as flow 651 as well as desorbed proteins in flow 616 on permeate/plasma side of membrane 612. Some non - exclusive examples of toxins 610 removed by the unit 600 are indoxyl sulfate that was bound to human albumin. Generally, the urea oxidation unit 700 removes small toxic molecules, while the toxin selective removal unit 600 removes large toxic molecules or those bound to proteins such as albumin. However, in different embodiments different arrangements of the toxin removal units are also possible. The blood and/or blood plasma flow 616 that exits from the toxin selective removal unit 600 continues to flow toward further elements/steps of the dialysis process or returns to the patient.
0014<figref idref="f0003">Figure 3</figref> is a schematic diagram of a dialysis system in operation in accordance with an embodiment of the present technology. The illustrated analysis system operates as a regeneration system for dialysate 715. In operation, blood flow 410, 805 flows between the vascular system of the patient, and the urea oxidation unit 700 and the toxin selective removal unit 600 (or other toxin removal units) generally requiring a pump (e.g., a pump 810). In some embodiments, the flow of dialysate 715 recirculates within the units 600, 700, therefore eliminating or at least limiting a need for adding fresh dialysate to the process. As a result, consumption of the dialysate is reduced with the embodiments of the inventive technology in comparison with the conventional dialysis.
0015The dialysate 715 may have a concentration of urea of 10 mM or less. In some embodiments, a controller 794 may control operation of pumps 810 and 716 to regulate the flow of blood input 410 and the dialysate 715.
0016<figref idref="f0004">Figure 4A</figref> is an exploded view of a urea treatment unit 20 in accordance with an embodiment of the present technology. Illustrated urea treatment unit 20 is a photo-electric urea treatment unit that removes urea by an electrochemical reaction. The system 20 includes two electrodes 24, 26 that are separated by a dielectric spacer 27 (e.g., rubber, silicon, or plastic spacer). In operation, dialysate that contains urea is held between the two electrodes 24, 26, and is subjected to photo-illumination that promotes photo-oxidation of urea into CO<sub>2</sub>, H<sub>2</sub>O and N<sub>2</sub>.
0017The required source of light may be provided by an ultraviolet (UV) lamp 22. The reaction also requires oxygen for the electrochemical reaction. Providing required oxygen is described with reference to <figref idref="f0004">Figure 4B</figref> below.
0018<figref idref="f0004">Figure 4B</figref> is a schematic diagram of a urea treatment unit in operation in accordance with an embodiment of the present technology. In the illustrated embodiment, air flows into tubing 28 and further to the dialysate the contains urea inside the photo-electric urea treatment unit 20. Arrows 29 indicate the incoming flow of air that produces bubbles 31 in the dialysate. However, the quantum efficiency for incident photons from the UV lamp 22 to electrochemical reaction may be relatively low, sometimes less than 1%. As a result, the urea treatment unit 22 may still be impractically large if the target of about 15 to 20 g of urea removal is to be achieved in a portable device. Improved provisioning of oxygen is described with respect to <figref idref="f0005">Figure 5A</figref> below.
0019<figref idref="f0005">Figure 5A</figref> is an exploded view of a urea treatment unit 720 in accordance with an embodiment of the present technology. The electrochemical reaction that takes place in the urea treatment unit 720 may be described as: <ul id="ul0002" list-style="none" compact="compact"><li>Anode: CO(NH<sub>2</sub>)<sub>2</sub> + 6 OH<sup>-</sup> -> CO<sub>2</sub> + N<sub>2</sub> + 5 H<sub>2</sub>O + 6e<sup>-</sup></li><li>Cathode: O<sub>2</sub> + 2 H<sub>2</sub>O + 4 e<sup>-</sup> -> 4 OH<sup>-</sup></li></ul><maths id="math0001" num="(Eq 1)"><math display="block"><mi>Net:</mi><mspace width="1ex" /><mi>CO</mi><msub><mfenced><msub><mi>NH</mi><mn>2</mn></msub></mfenced><mn>2</mn></msub><mo>+</mo><mn>3</mn><mo>/</mo><mn>2</mn><msub><mi mathvariant="normal">O</mi><mn>2</mn></msub><mo>→</mo><msub><mi>CO</mi><mn>2</mn></msub><mo>+</mo><msub><mi mathvariant="normal">N</mi><mn>2</mn></msub><mo>+</mo><mn>2</mn><msub><mi mathvariant="normal">H</mi><mn>2</mn></msub><mi mathvariant="normal">O</mi></math><img file="EP3749385B1_D0001.tif" /></maths>
0020In some embodiments, dialysate 715 flows through a spacer 732 from an inlet 734 to an outlet 736. Dialysate 715 carries urea that is to be electrochemically decomposed into CO<sub>2</sub> and N<sub>2</sub>. The spacer 732 may be sandwiched between an anode 722 and a cathode 742, each individually connected to a source of voltage 792 (e.g., a source of DC voltage). In some embodiments the source of voltage 792 provides voltage differential within a range from about 0.6 V to about 0.8 V. In some embodiment of spacer 732, the entire dialysate flow is directed to flow over TiO<sub>2</sub> layer.
0021The anode 722 is fitted with nanostructures (e.g., TiO<sub>2</sub> nanowires). In operation, the anode 722 is illuminated by a source of light that emits light (e.g., UV light) for the electrochemical reaction shown in equation 1. At the anode, photo-excited TiO<sub>2</sub> nanostructures provide holes for the oxidation of solution species on the surface, while electrons are collected on underlying conducting oxide (e.g., fluorine doped thin oxide or FTO), and then transported to the cathode electrode to split water into OH<sup>-</sup>. The photo-excitation may be provided by a source of light 750 or by natural light.
0022The cathode 742 is gas permeable (e.g., air permeable or oxygen permeable). In operation, flow of gas 760 that includes oxygen can pass through the cathode 742 toward the dialysate that includes urea.
0023In some embodiments, the urea treatment unit 720 may be used for preparing a dialysis fluid. For example, water to be treated may be passed between the anode 722 and the cathode 742 to oxidize impurities in the water to be treated, thereby generating the dialysis fluid. Some embodiments of the urea treatment unit 720 are further described with reference to <figref idref="f0006 f0007">Figures 5B - 6B</figref> below.
0024<figref idref="f0006">Figure 5B</figref> is an exploded view of a urea treatment unit 720 in accordance with an embodiment of the present technology. In some embodiments, the urea treatment unit 720 includes one or more nanostructured anodes 722 having a substrate 721 that carries nanostructures 723. The nanostructured anode 722 may be held in a substrate holder 724. The light required for the photo-chemical decomposition of the urea may be provided by a light array 752 that includes one or more sources of light (e.g., light emitting diodes (LEDs), lasers, discharge lamps, etc.). The sources of light may be arranged in a 2-dimensional (2D) array. In some embodiments, the LEDs emit light at 365 nm wavelength. In some embodiments, the LEDs emit light at an ultraviolet (UV) or visible light wavelength. In some embodiments, the LEDs generate light with the intensity of less than 4 mW/cm<sup>2</sup> at the surface of the anode (e.g., at the surface of the substrate 721). In other embodiments, other, higher light intensities may be used, for example light with the intensity of more than mW/cm<sup>2</sup> at the surface of the anode. In some embodiments, quantum efficiency of incident photons (incident photo-electric efficiency) is about 51%. In some embodiments, the nanostructured anode 722 may operate based on the incoming natural light in conjunction with or without dedicated light array 752.
0025As explained with reference to <figref idref="f0005">Figure 5A</figref>, the cathode is an air permeable cathode 742 that blocks liquids (e.g., water), but passes gases (e.g., air or oxygen) through. In some embodiments, the cathode 742 is made of conductive cloth. For example the conductive cloth may be a platinum-coated (Pt-coated) cloth or carbon cloth. In some embodiments, the cathode 742 may be a conductive paper-based cathode. The air permeable (air breathable) cathode 742 may be mechanically held in place by spacers 744 and 746 having supporting elements for the cathode 742, for example the spacers having mesh supporting elements 745, 747 (or other gas-permeable structural elements).
0026With at least some embodiments of the inventive technology, significant performance improvements were observed when compared to the performance of the conventional technology. For example, matching a daily urea production to the 6e-oxidation process for 15 gram (0.25 moles) a day target requires electrical current of 1.7A over a 24 hour period. With a target 1 mA/cm<sup>2</sup> photocurrent density on the TiO<sub>2</sub> nanostructured anode, the required total device area becomes about 1700 cm<sup>2</sup>, or 1.82 ft<sup>2</sup>. With such total device area it becomes feasible to deploy a backpack sized device that oxidizes about 15 g of urea per day. The backpack sized device would require about twelve 8000 mAh batteries for 8 hour operation without recharging and proportionally less batteries for shorter operations.
0027Furthermore, the high conversion efficiency of urea decomposition at low concentrations shows a high selectivity of TiO<sub>2</sub> to oxidize urea vs. generating oxochloro-species that are generally undesirable. Additionally, photocurrent density is more than one order of magnitude higher than that achieved by the prior art without nanostructures or LEDs.
Sample calculation of device performance
0028For the illustrated embodiment, the operating current of the UV LED was kept at 50 mA. With 6.7% of photons being geometrically incident on the TiO<sub>2</sub> sample, we can obtain the incident LED current to photoelectron current efficiency by <maths id="math0002"><math display="inline"><mi>η</mi><mo>=</mo><mfrac><msub><mi>I</mi><mi mathvariant="italic">photocurrent</mi></msub><mrow><mn>6.7</mn><mi>%</mi><mo>×</mo><msub><mi>I</mi><mi mathvariant="italic">LED</mi></msub></mrow></mfrac></math><img file="EP3749385B1_D0002.tif" /></maths>, where <i>I<sub>LED</sub></i> and <i>I<sub>photocurrent</sub></i> are the current used to drive the LED and the resultant photocurrent, respectively. Since the LED quantum efficiency is 40%, the incident photon to photoelectron efficiency <maths id="math0003"><math display="inline"><mi>η</mi><mo>′</mo><mo>=</mo><mfrac><mi>η</mi><mrow><mn>40</mn><mi>%</mi></mrow></mfrac></math><img file="EP3749385B1_D0003.tif" /></maths>. The total amount of photocurrent passing through the circuit is calculated with <i>Q<sub>total</sub> = ∫ I<sub>photocurrent</sub>dt.</i> Cumulative photocurrent that was used for urea decomposition can be calculated from urea concentration change, that is <i>Q<sub>urea</sub></i> = 6 × 96485 × (<i>C<sub>start</sub></i> - <i>C<sub>end</sub></i>) × <i>V,</i> where 6 is the number of electrons involved in oxidizing a single urea molecule times Faraday's constant, <i>C<sub>start</sub></i> and <i>C<sub>end</sub></i> are urea concentrations measured before and after the photo-oxidation experiment, and V is 0.3ml. Selectivity of the photocurrent towards urea decomposition is <maths id="math0004"><math display="inline"><mi>η</mi><mo>=</mo><mfrac><msub><mi>Q</mi><mi mathvariant="italic">urea</mi></msub><msub><mi>Q</mi><mi mathvariant="italic">total</mi></msub></mfrac></math><img file="EP3749385B1_D0004.tif" /></maths>. Urea removal rate is assumed to be constant during the operation. To calculate the required electrode area and operating current, we may assume 15 g of urea needs to be removed daily.
0029In contrast with the inventive technology, the prior art technology requires much higher operating current. To calculate the incident photon to photoelectron efficiency for the prior art technology as shown in Table 1 below, the solar AM .15 spectrum from NREL is used, which the light source in the literature was emulating. For the 100 mW/cm<sup>2</sup> intensity used in the literature, the total photon flux becomes 3.89 × <i>10<sup>17</sup>s<sup>-1</sup>cm<sup>-2</sup>,</i> out of which the photons between 280 nm and 380 nm have the flux of 1.16 × 10<sup>16</sup>s<sup>-1</sup>cm<sup>-2</sup>. Thus the incident photo to photonelectron efficiency is 0.28%. Even considering only the wavelengths below 380 nm, the efficiency remains only 9.3%. Assuming 40% quantum efficiency of the light source, same as the UV LED used in this study, this would require an operating current of 2000 A that is not practical in clinical, home or portable use.
0030Some comparisons of the performance of the present technology and the conventional technology is shown in Table 1 below. <tables id="tabl0001" num="0001"><table frame="all"><title>Table 1: Comparison between the present and conventional technology</title><tgroup cols="6"><colspec colnum="1" colname="col1" colwidth="24mm" /><colspec colnum="2" colname="col2" colwidth="27mm" /><colspec colnum="3" colname="col3" colwidth="35mm" /><colspec colnum="4" colname="col4" colwidth="27mm" /><colspec colnum="5" colname="col5" colwidth="24mm" /><colspec colnum="6" colname="col6" colwidth="30mm" /><thead valign="top"><row><entry /><entry>Incident photon to photoelectron efficiency</entry><entry>Efficiency of photocurrent toward urea decomposition</entry><entry>Typical Steady state photocurrent (mA/cm<sup>2</sup>)</entry><entry>Typical urea removal rate g/(cm<sup>2</sup>·hr)</entry><entry>Required electrode area for 15 g urea removal during 24 hrs (cm<sup>2</sup>)</entry></row></thead><tbody><row><entry>Present technology</entry><entry>51%</entry><entry>80%</entry><entry>0.8</entry><entry>2.66e-4</entry><entry>2,360 (2.5 sqft)</entry></row><row><entry>Conventional technology</entry><entry><0.1%</entry><entry>97%</entry><entry>0.011</entry><entry>4.03e-6</entry><entry>155,000</entry></row></tbody></tgroup></table></tables>
0031<figref idref="f0007">Figures 6A and 6B</figref> are microscope images of the nanostructures 723 at two different scales in accordance with an embodiment of the present technology. Generally, to improve performance of the TiO<sub>2</sub>, there is an inherent trade-off of having a sample that is thick enough to absorb all incoming light, but also thin enough to collect electron current without significant amounts of carrier recombination in the bulk of the substrate. In some embodiments, such optimization is obtained by the highly ordered nanoscale structures with high surface area and efficient electrical conduction to electron collection electrode (e.g., a substrate that is an FTO layer). In operation, relatively high density in the vertical direction of the nanostructures 723 allows for the separation of electrons/hole carriers, therefore reducing the inefficient carrier recombination. In some embodiments, the nanostructures 723 are about 500 nm thick.
0032<figref idref="f0008">Figure 7</figref> is a schematic view of a urea treatment unit in accordance with an embodiment of the present technology. The illustrated urea treatment unit 720 includes several cells 720-i (also referred to as urea treatment cells, dialysis-fluid regeneration cells, or photo-chemical oxidation cells). In different embodiments, the cells 720-i may share the same inlet and/or outlet. The flow of the dialysate through the cell may be arranged as a parallel or serial flow, or as a combination of both. In general, stacking the cells 720-i reduces the overall width and height of the system, therefore making the system more compact and portable.
0033<figref idref="f0009">Figure 8</figref> is flow diagram of a urea treatment unit 720 in accordance with an embodiment of the present technology. The urea treatment unit 720 includes multiple cells 720-i. A flow of dialysate enters a cell 720-1, where at least partial decomposition of the urea in the dialysate takes place, and continues towards other cells 720-i. Collectively, the electrochemical reaction in the cells 720-i convert the urea into the CO<sub>2</sub> and N<sub>2</sub> as explained with reference to Equation 1 above. In general, arranging the cells 720-i may make the system more modular and/or less expensive.
0034<figref idref="f0010">Figure 9</figref> is a schematic view of a portable urea dialysis system 100 in accordance with an embodiment of the present technology. The illustrated system 100 includes multiple cells 720-i having multiple dialysate inlets and outlets 734, 736. The flow through the cells 720-i may be arranged as shown in <figref idref="f0008 f0009 f0010">Figures 7-9</figref>. As a result, size of the urea dialysis system 100 may be reduced to such an extent that the system becomes portable, for example, the system may be fitted within a backpack or other carrier 105.
0035<figref idref="f0011 f0012 f0013 f0014">Figures 10A-10D</figref> are schematic views of portable dialysis systems in accordance with embodiments of the present technology. In some embodiments of the inventive technology, the compactness of the dialysis system may enable wearability or portability of the system. Such wearability/portability of the dialysis system promotes mobility and quality of life of the patient.
0036<figref idref="f0011">Figure 10A</figref> illustrates a portable dialysis system 100 that is attached to a body of the patient 5. The portable dialysis system 100 is connected to the vascular system of the patient with a tube 110, with other possible embodiments of vascular access locations. <figref idref="f0012">Figure 10B</figref> illustrates a portable dialysis system 100 that includes the urea treatment unit 720 that can be fitted within the backpack 105. <figref idref="f0013">Figure 10C</figref> illustrates a portable dialysis system 100 that includes the urea treatment unit 720 that can be fitted within a suitcase 105. <figref idref="f0014">Figure 10D</figref> illustrates a portable dialysis system 100 that includes the urea treatment unit that can be fitted within a case 105. Other examples of the portable dialysis system 100 are also possible in different embodiments.
0037<figref idref="f0015">Figure 11</figref> is a graph of photocurrent in accordance with an embodiment of the present technology. The horizontal axis of the graph shows time in seconds, and the vertical axis shows the photocurrent in mA/cm<sup>2</sup>. Data were obtained by illuminating the TiO<sub>2</sub> nanostructures that were manufactured by hydrothermal synthesis (upper curve) and dip coating (lower curve). When acquiring data, the LED is turned on (50 mA) at 5 s into the measurements; 0V is applied to TiO<sub>2</sub>; and static urea/NaCl solution is used. The TiO<sub>2</sub> film that was made by hydrothermal synthesis shows high initial current. This initial current is mass-transport limited and has about 8X higher steady state photocurrent than the TiO<sub>2</sub> film that was prepared by dip coating. The effective LED intensity on the TiO<sub>2</sub>/FTO substrate was 4 mW/cm<sup>2</sup>.
0038<figref idref="f0016">Figure 12</figref> is a graph of photocurrent as a function of hydrothermal growth time in accordance with an embodiment of the present technology. The horizontal axis of the graph shows time in seconds, and the vertical axis shows the photocurrent in mA/cm<sup>2</sup>. The effective LED intensity on TiO<sub>2</sub>/FTO substrate was 4 mW/cm<sup>2</sup>. A steady state photocurrent as a function of hydrothermal growth time shows optimal growth time at about 185 min (corresponding to the maximum photocurrent).
0039<figref idref="f0017">Figure 13</figref> is a graph of absorbance as a function of wavelength in accordance with an embodiment of the present technology. The horizontal axis of the graph shows wavelength of the incoming light in nanometers, and the vertical axis shows the absorbance in atomic units. Ultraviolet light absorbance spectra generally increases with the hydrothermal growth time (the time steps being the same as those shown sequentially in <figref idref="f0016">Figure 12</figref> above).
0040<figref idref="f0018">Figure 14</figref> is a graph of photocurrent as a function of effective LED current (light intensity) in accordance with an embodiment of the present technology. The horizontal axis of the graph shows effective LED current in mA, and the vertical axis shows the photocurrent in mA/cm<sup>2</sup>. The round symbols correspond to the applied cathode-to-anode voltage potential of 0.8 V, and the diamond symbols correspond to the case with no cathode-to-anode voltage. Thus, the graph shows a steady state photocurrent increase significantly with +0.8V applied bias to the TiO<sub>2</sub> anode. The increase is due to separating electron hole pairs in TiO<sub>2</sub>, pushing holes to reaction surface and drawing electrons into cathode circuit. The effective LED current is the portion of the LED current that is responsible for the photons incident on the substrate being tested (the LED having 40% quantum efficiency). Due to the device geometry, only 6.7% of emitted photons were incident on the TiO<sub>2</sub> surface (i.e., on the TiO<sub>2</sub> substrate surface).
0041<figref idref="f0019">Figure 15</figref> is a performance comparison between a Pt-coated and a Pt-black cathode in accordance with an embodiment of the present technology. The horizontal axis of the graph shows time in seconds, and the vertical axis shows the photocurrent in mA/cm<sup>2</sup>. The LED light was turned on at about 5 s with 0 V applied to anode, and with a static urea solution. The effective LED intensity on TiO<sub>2</sub>/FTO substrate was 4 mW/cm<sup>2</sup>. For the Pt-black electrode, air bubbles (2 mL/min) were introduced at 370 s. This event causes the sudden increase in the photocurrent for the Pt-black cathode. Nevertheless, the Pt-coated cathode consistently outperformed the Pt-black cathode in terms of the photocurrent.
0042<figref idref="f0020">Figure 16</figref> is a graph of photocurrent as a function of time in accordance with an embodiment of the present technology. The effective LED intensity on TiO<sub>2</sub>/FTO substrate was 4 mW/cm<sup>2</sup>. The results demonstrate almost continuous operation of a prototype device running for over 100 h in a circulated (0.3 ml/min) solution of 10 mM urea and 0.15 M NaCl.
0043Many embodiments of the technology described above may take the form of computer- or controller-executable instructions, including routines executed by a programmable computer or controller. Those skilled in the relevant art will appreciate that the technology can be practiced on computer/controller systems other than those shown and described above. The technology can be embodied in a special-purpose computer, controller or data processor that is specifically programmed, configured or constructed to perform one or more of the computer-executable instructions described above. Accordingly, the terms "computer" and "controller" as generally used herein refer to any data processor and can include Internet appliances and hand-held devices (including palm-top computers, wearable computers, cellular or mobile phones, multiprocessor systems, processor-based or programmable consumer electronics, network computers, mini computers and the like). The term "about" means +/- 5% of the stated value.
0044From the foregoing, it will be appreciated that specific embodiments of the technology have been described herein for purposes of illustration, but that various modifications may be made without deviating from the disclosure. Moreover, while various advantages and features associated with certain embodiments have been described above in the context of those embodiments, other embodiments may also exhibit such advantages and/or features, and not all embodiments need necessarily exhibit such advantages and/or features to fall within the scope of the technology.
Contents5
24 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24
Every citation, both ways
| Document | Relation | Office |
|---|---|---|
| WO2017116515A1 | Cites | World Intellectual Property Organization (WIPO) |
| CN104870372A | Cites | China |
| DE69732971T2 | Cites | Germany |
| KR20110033866A | Cites | Republic of Korea |
| KR20140024853A | Cites | Republic of Korea |
| KR20180089153A | Cites | Republic of Korea |
| TW201529470A | Cites | Taiwan Province of China |
| US3994799A | Cites | United States of America |
| US5951863A | Cites | United States of America |
| US2003217928A1 | Cites | United States of America |
| US2014158986A1 | Cites | United States of America |
| US2014272183A1 | Cites | United States of America |
| US2014288351A1 | Cites | United States of America |
| US2015209500A1 | Cites | United States of America |
| US2017087291A1 | Cites | United States of America |
| US2017189594A1 | Cites | United States of America |
| US2017341942A1 | Cites | United States of America |
| PARK SOONA ET AL: "Photocatalytic oxidation of urea on TiO2 in water and urine: mechanism, product distribution, and effect of surface platinization", ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH INTERNATIONAL, ECOMED, LANDSBERG, DE, vol. 26, no. 2, 4 February 2017 (2017-02-04), pages 1044-1053, XP036675323, ISSN: 0944-1344, DOI: 10.1007/S11356-017-8380-3 [retrieved on 2017-02-04] | Non-patent | – |
| KANEKO M ET AL: "Biophotochemical cell (BPCC) to photodecompose biomass and bio-related compounds by UV irradiation with simultaneous electrical power generation", JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY, A: CHEMISTRY, ELSEVIER SEQUOIA, LAUSANNE, CH, vol. 205, no. 2-3, 25 June 2009 (2009-06-25), pages 168-172, XP026173013, ISSN: 1010-6030, DOI: 10.1016/J.JPHOTOCHEM.2009.04.024 [retrieved on 2009-05-09] | Non-patent | – |
| SHAO GUOZHENG ET AL: "TiO 2 Nanowires Based System for Urea Photodecomposition and Dialysate Regeneration", ACS APPLIED NANO MATERIALS, vol. 2, no. 10, 9 October 2019 (2019-10-09), pages 6116-6123, XP055791464, ISSN: 2574-0970, DOI: 10.1021/acsanm.9b00709 Retrieved from the Internet: URL:https://pubs.acs.org/doi/pdf/10.1021/a csanm.9b00709> | Non-patent | – |
45 members in 18 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 201862719549P | United States of America | – | |
| 201862719549 | United States of America | P | |
| 2019044285 | United States of America | W |
Members45
| Document | Office | Kind | |
|---|---|---|---|
| CA3108771A1 | Canada | A1 | |
| US2020054810A1 | United States of America | A1 | |
| US2020054811A1 | United States of America | A1 | |
| WO2020036732A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW202015746A | Taiwan Province of China | A | |
| MX2020009679A | Mexico | A | |
| IL277205A | Israel | A | |
| IL277205D0 | Israel | D0 | |
| CN112040999A | China | A | |
| EP3749385A1 | European Patent Office (EPO) | A1 | |
| US10894118B2 | United States of America | B2 | |
| AU2019320727A1 | Australia | A1 | |
| BR112020022074A2 | Brazil | A2 | |
| KR20210032520A | Republic of Korea | A | |
| SG11202100659TA | Singapore | A | |
| US10973971B2 | United States of America | B2 | |
| EP3749385A4 | European Patent Office (EPO) | A4 | |
| US2021205521A1 | United States of America | A1 | |
| JP2021535769A | Japan | A | |
| NZ772265A | New Zealand | A | |
| ZA202101012B | South Africa | B | |
| AU2019320727B2 | Australia | B2 | |
| EP3749385B1This record | European Patent Office (EPO) | B1 | |
| AU2022203849A1 | Australia | A1 | |
| IL277205B | Israel | B | |
| DK3749385T3 | Denmark | T3 | |
| PT3749385T | Portugal | T | |
| KR102424503B1 | Republic of Korea | B1 | |
| KR20220104842A | Republic of Korea | A | |
| IL294390A | Israel | A | |
| ES2920480T3 | Spain | T3 | |
| EP4091646A1 | European Patent Office (EPO) | A1 | |
| CA3108771C | Canada | C | |
| US11684707B2 | United States of America | B2 | |
| BR112020022074B1 | Brazil | B1 | |
| TWI818055B | Taiwan Province of China | B | |
| IL294390B1 | Israel | B1 | |
| JP7488251B2 | Japan | B2 | |
| IL294390B2 | Israel | B2 | |
| AU2022203849B2 | Australia | B2 | |
| CN112040999B | China | B | |
| KR102783086B1 | Republic of Korea | B1 | |
| EP4091646B1 | European Patent Office (EPO) | B1 | |
| EP4091646C0 | European Patent Office (EPO) | C0 | |
| ES3017333T3 | Spain | T3 |
79 legal events, as 13 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Full renewal or maintenance fee paidST27 STATUS EVENT CODE: U-0-0-U10-U11 (AS PROVIDED BY THE NATIONAL OFFICE)U11 | U11 | CH | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Publication of translation of european patent specificationUEP | UEP | AT | |
| Opt-out of the competence of the unified patent court (upc) registeredP01 | P01 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Ep patent validated in greeceEP | EP | GR | |
| Invalidation of extension of european patentsMG9D | MG9D | LT | |
| Definitive protectionFG2A | FG2A | ES | |
| Translation for ep filed (entry of ep into country)FP | FP | NL | |
| Translation of granted ep patentGrantedTRGR | TRGR | SE | |
| Translation is availableAVAILABILITY OF NATIONAL TRANSLATIONSC4A | SC4A | PT | |
| Ep patent with danish claimsT3 | T3 | DK | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| Reference to at number (ep patent validated in austria)REF | REF | AT | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE PATENT HAS BEEN GRANTEDSTAA | STAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: GRANT OF PATENT IS INTENDEDSTAA | STAA | EP | |
| Request for validation of the european patent (deleted)DAV | DAV | EP | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: REQUEST FOR EXAMINATION WAS MADESTAA | STAA | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADESTAA | STAA | EP |
Numbers
- Publication
- 3749385
- Application
- 198490831
Titles3
- German
- VORRICHTUNG ZUR HARNSTOFFPHOTOOXIDATION
- English
- APPARATUS FOR UREA PHOTO-OXIDATION
- French
- APPAREIL DE PHOTO-OXYDATION DE L'URÉE
Classification
- CPC, 25
- A61M1/1696
- A61M2209/088
- A61M1/3486
- A61M1/3468
- A61M1/3413
- A61M2202/0498
- A61M2209/084
- A61L2/08
- B01J21/063
- C02F1/4672
- C02F1/325
- C02F2001/46161
- C02F2103/026
- C02F2201/3222
- C02F2305/10
- C02F2101/38
- B01J35/39
- A61L2/084
- A61L2103/05
- A61L2/10
- A61M1/3406
- A61M1/287
- A61M1/3472
- A61M1/3679
- A61M2202/0057
- IPC, 5
- A61M1 16
- A61M1 14
- A61M1 34
- B01J21 06
- B01J35 00
Designated states1
- Contracting states, 1
- Türkiye
